Director Jung Min Bae’s Lecture on Future Treatments at the Busan-Ulsan-Gyeongnam Academic Conference
Director Jung Min Bae gave a lecture on the present and future of vitiligo treatment at the Busan-Ulsan-Gyeongnam Dermatological Association academic conference, covering topics from phototherapy and excimer laser techniques to the prospects of the new drug JAK inhibitors.
Invited to the 18th Busan-Ulsan-Gyeongnam Dermatological Association Academic Conference, he presented a vision for vitiligo treatment, including JAK inhibitors, which are gaining attention as new drugs.
On a clear autumn day, Heal House Dermatologists are always at the center of academic conferences held across the country with their dedicated efforts. Chief Dermatologist Jung Min Bae visited Busan as a speaker at the 18th Busan-Ulsan-Gyeongnam Dermatological Society Conference, delivering an in-depth lecture that provided fellow doctors in the Yeongnam region with a perspective on the present and future of vitiligo treatment.
He shared detailed techniques for using phototherapy and excimer lasers, which are currently the most effective treatments, and also covered the mechanism of action and future prospects of the innovative new drug JAK inhibitors, which are undergoing global clinical trials, signaling upcoming changes in the medical environment.
Vitiligo treatment should not rely on a single method; it is important to appropriately consider both existing and new treatments based on the patient's condition. When new drugs are introduced, it is also crucial to thoroughly review the evidence regarding their efficacy and safety and to apply them carefully in actual clinical practice.
Heal House will continue to carefully apply currently available treatments while steadily monitoring newly accumulated research findings to guide patients toward a broader range of treatment options.
Was this article helpful?
